UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000006085
Receipt No. R000007204
Scientific Title A feasibility study of sequential Anthracycline-based regimen and Nab-Paclitaxel / Trastuzumab followed by Trastuzumab as postoperative adjuvant chemotherapy for Her2 positive breast cancer.(SBCCSG-22)
Date of disclosure of the study information 2011/08/01
Last modified on 2018/12/18 20:10:30

No. Disposal Last modified on Item of update
1 Insert 2011/07/31 16:14:49
2 Update 2014/01/31 18:26:57 Email
3 Update 2015/02/16 19:12:42 Recruitment status
Last follow-up date
4 Update 2017/11/30 18:07:38 UMIN ID1
5 Update 2018/12/18 20:10:30 Recruitment status
Last follow-up date

Contact us.